The coronavirus vaccines have been making headlines for a while now for all kinds of reasons. Most of them are surrounded by all kinds of controversies especially due to their potential side effects. These can be extremely severe for some people and the issue is currently analyzed by experts.
Now, Astra Zeneca is making headlines, but this time is due to another reason.
AstraZeneca vaccine changes its name
ABC.net.au just noted that the AstraZeneca vaccine will now be called Vaxzevria after an application to rename it was approved by Australia’s medical regulator.
It’s been also reported that the company asked the Therapeutic Goods Administration (TGA) to approve the rebrand – it said that it would bring the name into line with what the vaccine is called in European countries and Canada.
The same online publication mentioned above notes that there were concerns if the name was different in Australia, it could lead to other countries not recognising the vaccine on the vaccine passports when international travel resumes.
According to the reports, the TGA said it hoped the change in name would make sure there would be no confusion in the future.
“This is expected to alleviate confusion and further clarify that the vaccine produced by CSL and Seqirus in Melbourne is the same as that produced internationally,” the statement said.
The same statement continued and explained the following:
“This name change will also help facilitate international recognition for Australians who have been vaccinated with the AstraZeneca vaccine.”
Coronavirus vaccines in the news
It’s been just revealed by the latest reports that the US experts are expected to recommend Covid 19 vaccine boosters for all Americans.
Yahoo News notes that this will be happening for everyone, regardless of age, eight months after they received their second dose of the shot. This way, people will ensure lasting protection against the coronavirus as the delta variant spreads across the country.
Stay tuned for more news.